These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 25769577)

  • 61. Circulating tumour necrosis factor receptors 1 and 2 predict contrast-induced nephropathy and progressive renal dysfunction: a prospective cohort study.
    An JN; Yoo KD; Hwang JH; Kim HL; Kim SH; Yang SH; Kim JH; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
    Nephrology (Carlton); 2015 Aug; 20(8):552-9. PubMed ID: 25783484
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Defining incidence and outcome of contrast-induced nephropathy among trauma: is it overhyped?
    Kulvatunyou N; Rhee PM; Carter SN; Roberts PM; Lees JS; Bender JS; Albrecht RM
    Am Surg; 2011 Jun; 77(6):686-9. PubMed ID: 21679633
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol.
    Werner S; Bez C; Hinterleitner C; Horger M
    PLoS One; 2020; 15(5):e0233433. PubMed ID: 32437415
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of the usefulness of gadodiamide and iodine mixture versus iodinated contrast alone for prevention of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography.
    Reed PS; Dixon SR; Boura JA; O'Neill WW; Kahn JK
    Am J Cardiol; 2007 Oct; 100(7):1090-3. PubMed ID: 17884368
    [TBL] [Abstract][Full Text] [Related]  

  • 65. N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
    Goussot S; Mousson C; Guenancia C; Stamboul K; Brunel P; Brunet D; Touzery C; Cottin Y; Zeller M
    Am J Cardiol; 2015 Sep; 116(6):865-71. PubMed ID: 26183794
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease.
    Toprak O; Cirit M; Yesil M; Bayata S; Tanrisev M; Varol U; Ersoy R; Esi E
    Nephrol Dial Transplant; 2007 Mar; 22(3):819-26. PubMed ID: 17090607
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Incidence of Contrast-Induced Nephropathy After Renal Graft Catheter Arteriography Using Iodine-Based Contrast Medium.
    Fananapazir G; Troppmann C; Corwin MT; Bent CK; Vu CT; Lamba R
    AJR Am J Roentgenol; 2016 Apr; 206(4):783-6. PubMed ID: 26866337
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
    Geng W; Fu XH; Gu XS; Wang YB; Wang XC; Li W; Jiang YF; Hao GZ; Fan WZ; Xue L
    Chin Med J (Engl); 2012 Oct; 125(19):3368-72. PubMed ID: 23044290
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
    Marenzi G; Ferrari C; Marana I; Assanelli E; De Metrio M; Teruzzi G; Veglia F; Fabbiocchi F; Montorsi P; Bartorelli AL
    JACC Cardiovasc Interv; 2012 Jan; 5(1):90-7. PubMed ID: 22230154
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention.
    Jabara R; Gadesam RR; Pendyala LK; Knopf WD; Chronos N; Chen JP; Viel K; King SB; Manoukian SV
    Am J Cardiol; 2009 Jun; 103(12):1657-62. PubMed ID: 19539072
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study.
    Rim MY; Ro H; Kang WC; Kim AJ; Park H; Chang JH; Lee HH; Chung W; Jung JY
    Am J Kidney Dis; 2012 Oct; 60(4):576-82. PubMed ID: 22658321
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Contrast-induced nephropathy in invasive cardiology.
    Perrin T; Descombes E; Cook S
    Swiss Med Wkly; 2012; 142():w13608. PubMed ID: 22714555
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.
    Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; Ommen VV; Wildberger JE
    Lancet; 2017 Apr; 389(10076):1312-1322. PubMed ID: 28233565
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT) - a clinical problem in daily practice? A multicenter observational study.
    Lencioni R; Fattori R; Morana G; Stacul F
    Acta Radiol; 2010 Sep; 51(7):741-50. PubMed ID: 20707658
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Prevention of contrast-induced acute kidney injury].
    Guastoni C; De Servi S; Covella P; Turri C; Gidaro B; Bellotti N; Stasi A
    G Ital Nefrol; 2012; 29 Suppl 58():S33-45. PubMed ID: 23229601
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of a continuous quality improvement program on contrast-induced nephropathy in outpatients with chronic kidney disease: an interrupted time-series study.
    Hirano K; Kobayashi D; Shimbo T; Komatsu Y
    Nephrol Dial Transplant; 2023 May; 38(5):1249-1259. PubMed ID: 36099912
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A Retrospective Review of Contrast Nephropathy in a General Population.
    Arayan A; Nigogosyan MA; Van Every MJ
    WMJ; 2015 Jun; 114(3):95-9. PubMed ID: 27073827
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Contrast-induced nephropathy: Pathophysiology, risk factors, and prevention.
    Hossain MA; Costanzo E; Cosentino J; Patel C; Qaisar H; Singh V; Khan T; Cheng JS; Asif A; Vachharajani TJ
    Saudi J Kidney Dis Transpl; 2018; 29(1):1-9. PubMed ID: 29456202
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risk factors for contrast-induced nephropathy and their association with mortality in patients with blunt splenic injuries.
    Hsieh TM; Tsai TH; Liu YW; Hsieh CH
    Int J Surg; 2016 Nov; 35():69-75. PubMed ID: 27622729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.